A major advance in cancer research is arising with the use of nanobodies to re-engage dysfunctional p53. This crucial malignant inhibitor protein is frequently lost in many types of tumors, leading uncontrolled body https://ok-social.com/story7548471/mini-antibodies-restore-tumor-suppressor-p53-the-potential-hope-for-tumor-management